ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1964

Epigenetic Changes of Energy Metabolism-Related Genes in Rheumatoid Arthritis Fibroblast-like Synoviocytes

Brian Pedersen1, Roxana Coras1,2, Wei Wang3, Gary S. Firestein1 and Monica Guma1,2, 1Medicine, University of California San Diego, La Jolla, CA, 2Medicine, Autonomous University of Barcelona, Bellatera, Spain, 3Chemistry and Biochemistry, University of California San Diego, La Jolla, CA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Bioinformatics, Epigenetics, Fibroblasts, metabolism and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Genetics, Genomics and Proteomics Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Epigenetic changes contribute to the pathogenesis of rheumatoid arthritis (RA) and a comprehensive epigenomic characterization of RA fibroblast-like synoviocytes (FLS) has recently been described. As previous studies indicate that energy metabolism is altered in RA FLS, we hypothesize that ChIP mark changes near energy metabolism-related genes would correlate with differences in expression of these genes.

Methods: ChIP-sequencing data, for six different ChIP marks (H3K4me1, H3K4me3, H3K9me3, H3K27ac, H3K27me3, H3K36me3) from publicly available data sets from FLS derived from 11 patients with RA and 11 patients with OA were compared to identify regions with a difference in these histone modifications. Single nearest genes to regions of interest were then utilized for pathway analyses (Gene Ontology Enrichment Analysis, KEGG pathways, PANTHER classification) to determine if particular cellular processes and pathways are associated with these chromatin changes. Pathways associated with energy metabolism were enriched near a ChIP mark change commonly associated with active transcription (H3K4me3) with the use of the whole genome as a reference. To further elucidate these findings, single nearest genes associated with any ChIP mark change and metabolism were utilized for a secondary pathway analysis. Additionally, changes in transcription of genes associated with the ChIP mark changes were assessed using RNA-sequencing data from the same cells used for the ChIP-sequencing analyses.

Results: As per the unbiased pathway analysis, 4 of the 21 pathways significantly associated with changes in H3K4me3 (p<0.05) were associated with energy metabolism with the whole genome used as a background (including glucose 6-phosphate metabolic process, regulation of triglyceride biosynthetic process and arginine metabolic process). 44 different genes involved in energy metabolism were associated with a change in at least one of the ChIP marks. These 44 genes were then used in a KEGG pathway analysis. Glycolysis/Gluconeogenesis was one of the top ranked pathways with 11 out of the 44 genes involved in this pathway (adjusted p= 2.89e-21). Of the 44 genes associated with a change in a ChIP mark, glutaminase (GLS) and the cysteine/glutamate transporter SLC7A11 were two genes with significant differences in expression as per RNA-sequencing data. Of note, both genes were shown to mediate tumor metabolic reprograming and to promote cancer progression.

Conclusion: This study of RA FLS demonstrated changes in epigenetic marks of genes related to energy metabolism and suggests that these pathways can be critical in RA pathogenesis and be involved in the imprinted aggressive phenotype displayed by RA FLS compared to OA FLS. Additionally, this dataset has the potential to identify RA-specific targets that can be used to develop novel therapeutic agents.


Disclosure: B. Pedersen, None; R. Coras, None; W. Wang, None; G. S. Firestein, None; M. Guma, None.

To cite this abstract in AMA style:

Pedersen B, Coras R, Wang W, Firestein GS, Guma M. Epigenetic Changes of Energy Metabolism-Related Genes in Rheumatoid Arthritis Fibroblast-like Synoviocytes [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/epigenetic-changes-of-energy-metabolism-related-genes-in-rheumatoid-arthritis-fibroblast-like-synoviocytes/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/epigenetic-changes-of-energy-metabolism-related-genes-in-rheumatoid-arthritis-fibroblast-like-synoviocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology